AL
ACOR

Airain Ltd’s Acorda Therapeutics ACOR Stock Holding History

Airain Ltd’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-204
Closed -$646K – 953
2016
Q1 		$646K Buy
204
+79
+63% +$328K 0.04% 382
2015
Q4 		$640K Buy
125
+42
+51% +$184K 0.04% 405
2015
Q3 		$264K Buy
+83
New +$322K 0.02% 626
2015
Q2 		– Sell
-53
Closed -$211K – 1142
2015
Q1 		$211K Sell
53
-194
-79% -$889K 0.01% 701
2014
Q4 		$1.21M Buy
247
+115
+87% +$494K 0.1% 239
2014
Q3 		$536K Buy
+132
New +$495K 0.04% 436
2014
Q1 		– Sell
-238
Closed -$833K – 899
2013
Q4 		$833K Buy
238
+186
+358% +$725K 0.11% 211
2013
Q3 		$215K Buy
+52
New +$224K 0.04% 389

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Airain Ltd's ACOR Position: Q2 2016 in Review

Airain Ltd sold out of Acorda Therapeutics (ACOR) in Q2 2016, closing a stake of 204 shares — an estimated $646K sold.

Airain Ltd first reported a position in ACOR in Q3 2013 and held it in 8 quarters. The position peaked at $1.21M in Q4 2014. 175 funds tracked by Wall St. Rank hold ACOR as of Q2 2016.

  • Airain Ltd reported no remaining Acorda Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Airain Ltd sold 204 Acorda Therapeutics shares in Q2 2016, an estimated $646K.
  • Airain Ltd first reported a position in Acorda Therapeutics in Q3 2013 and held it in 8 quarters.
  • Airain Ltd's Acorda Therapeutics position peaked at $1.21M in Q4 2014.
  • 175 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2016.

Based on Airain Ltd's 13F filing for Q2 2016, filed 5 Aug 2016.